Wednesday, March 26, 2014 by Lee Mannering
In today’s Federal Register, the U.S. Food and Drug Administration announced it was opening an advanced notice of proposed rulemaking to solicit comments, data, and information to help implement changes to the Reportable Food Registry. Per the Food Safety Modernization Act, FDA may require a responsible party to also submit to the agency “consumer-oriented” information regarding certain reportable foods, including information necessary to enable a consumer to accurately identify whether the consumer is in possession of a reportable food. In addition, FDA must prepare and publish on its website a one-page summary of the consumer-oriented information that can be easily printed by a grocery store for the purposes of consumer notification.
FDA is seeking input on topics including consumer-oriented information submissions, consumer notifications, posting consumer notifications in grocery stores, and grocery stores subject to the new requirements. These comments are due June 9.
Also in the Federal Register, FDA announced it was extending the comment period for designation of high-risk foods for tracing. As discussed previously here on Field to Fork, Per the FSMA, high-risk foods must be based on a number of factors; some of these include:
- the known safety risks of a particular food, including the history and severity of foodborne illness outbreaks attributed to such food, taking into consideration foodborne illness data collected by the Centers for Disease Control and Prevention;
- the likelihood that a particular food has a high potential risk for microbiological or chemical contamination or would support the growth of pathogenic microorganisms due to the nature of the food or the processes used to produce such food; and
- the likelihood that consuming a particular food will result in a foodborne illness due to contamination of the food among others.
Comments are on the designation of high-risk foods notice are now due May 22.
For more details, visit our FSMA Resource Center to learn more about the various provisions of the FSMA and PMA’s interaction with FDA on these proposals.